Heart Lung . COVID-19 Suspected myopericarditis without pulmonary involvement

[tetano]

Heart Lung


. 2021 Oct 9;51:14-16.
doi: 10.1016/j.hrtlng.2021.10.001. Online ahead of print.
COVID-19 Suspected myopericarditis without pulmonary involvement


Steven Mirabella ¹ , Oshin Bansode ² , Hyfaa Mashaal ² , Jagadish Akella ²



Affiliations

• PMID: 34731691
• DOI: 10.1016/j.hrtlng.2021.10.001

Abstract

Myopericarditis is a rare consequence of COVID-19 infection. Although extremely rare, COVID-19 can present without pulmonary involvement, and there have been reports of isolated cardiac involvement in one prior case We report a case of a young African American man presenting with myopericarditis following a recently recovered COVID-19 infection. Complicated by ICU admission requiring vasopressors; with eventual resolution following initiation of aspirin and colchicine for myopericarditis. Life threatening myopericarditis can occur following resolution of COVID-19 disease. The degree of cardiac involvement correlates poorly to the severity of pulmonary involvement.

Keywords: Acute coronary syndrome; COVID-19; Cardiac; Coronavirus; Coronavirus infections; Myocarditis; Myocytes; Patient discharge; Pericardial effusion; Pericardiocentesis; Severe acute respiratory syndrome coronavirus 2.